Navigation Links
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
Date:11/8/2007

Molecular Endocrinology at the University of Chicago with Drs. Kenneth Polonski and Graham Bell. His clinical and research interests in diabetes and obesity were focused during his work at the Sansum Diabetes Research Institute which led him to join Amgen to build the Metabolic Disease Area and direct the Leptin program. At Amgen he also directed the development of a broad array of metabolic disease targets focused on translating novel pathways into the clinic. These pathways include 11 Beta HSD-1, RANK Ligand, calcium sensing receptor, PPAR-gamma modulation, and MCH-R1. He also maintains his clinical practice.

About InteKrin (http://www.InteKrin.com):

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes and metabolic disease. InteKrin's business strategy is to build a robust portfolio of high value products by in-licensing clinical-stage therapeutic candidates that address significant unmet medical needs and rapidly move them through critical development stages under the direction of InteKrin's accomplished management team and world-class SAB. The company was co-founded by Chief Executive Denny Lanfear, a former Amgen VP and Officer, and by Scientific Advisory Board Chair Christos Mantzoros, M.D., D.Sc., a leading clinical endocrinologist and Associate Professor at Harvard Medical School. InteKrin's team of world-class scientific and medical experts includes veterans from several successful biopharma organizations, internationally recognized experts in nuclear receptors and metabolism, top scientists formerly with the Food and Drug Administration and key clinical and commercialization leaders who brought earlier PPAR agonists to market.

InteKrin's lead therapeutic candidate, INT131, is a potent non-TZD SPPARM (Selective Peroxisome Proliferator-Activated Receptor Modulator) that was specifically engineered to have equal or better efficacy to the cu
'/>"/>

SOURCE InteKrin Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. WorldHeart Appoints David Pellone Chief Financial Officer
9. Novo Nordisk Appoints New Leader of North American Business
10. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
11. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
(Date:12/25/2014)... LunaDress.co.uk has updated its blog to provide professional shopping tips on ... models at LunaDress.co.uk come with big discounts, up to 80 percent ... turn out to be a most exciting memory and can show ... surprise to a wedding. On the updated fashion blog, ladies can ... a big day . , Going out with friends to a ...
(Date:12/25/2014)... (HealthDay News) -- The risk of burns from fires ... need to be extra cautious, an expert says. ... significant increase in patients coming in with burns," said ... Volunteer Firefighters Burn Center of Stony Brook University Hospital ... of joy, but if not careful, could quickly turn ...
(Date:12/25/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- Among early ... treatment, less than half of one percent will eventually ... new analysis reveals. The finding comes from a ... between 1998 and 2007, and it suggests that the ... double what experts had previously thought. "The frequency ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... The AACR will present the 2011 AACR-Prevent Cancer ... Andrew J. Dannenberg, M.D., at the 10th AACR International ... 22-25, 2011. Dannenberg is director of the Weill Cornell ... York-Presbyterian/Weill Cornell Medical Center. He is also the Henry ...
... (HealthDay News) -- Although pregnant women who have high blood ... born with birth defects, new research indicates that the medications ... risk any further. The finding suggests that the widely ... enzyme (ACE) inhibitors are safe to use during the first ...
... innovative, minimally invasive ways to treat liver cancerand being ... of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for ... are reported in studies in the October Journal ... these two new studies may be beneficial to patients ...
... MD, is to receive the 2011 Morris F. Collen ... recognition of his personal commitment and dedication to informatics, ... field. Dr. Tierney, president and CEO of the Regenstrief ... of Medicine and holds the Sam Regenstrief Chair in ...
... successful initial testing of a new tool that tells ... operation is underway, so that surgeons can remove more ... survival. The report appears in ACS, journal Analytical ... that cancer can recur if tumor cells remain in ...
... assessment tool was an effective way of identifying violent hospital ... in the November issue of the Journal of Advanced ... Kim, Professor of Nursing at Point Loma Nazarene University and ... Diego, California, studied more than 2,000 patients admitted to an ...
Cached Medicine News:Health News:Andrew J. Dannenberg, M.D., honored with AACR-Prevent Cancer Foundation Award 2Health News:Hypertension, Not Blood Pressure Drugs, Linked to Birth Defects 2Health News:Interventional radiologists: Tough on liver cancer, kind to patients 2Health News:Interventional radiologists: Tough on liver cancer, kind to patients 3Health News:Interventional radiologists: Tough on liver cancer, kind to patients 4Health News:AMIA honors Regenstrief Institute's President and CEO with 2011 Morris F. Collen Award 2Health News:AMIA honors Regenstrief Institute's President and CEO with 2011 Morris F. Collen Award 3Health News:New aggression tool predicted violent patients in medical and surgical wards 2
(Date:12/22/2014)... 2014 NxStage Medical, Inc. (NASDAQ: ... products, announced today that the U.S. Food and ... to perform hemodialysis overnight while the patient is ... NxStage,s® System One is the first and only ... indication. Home nocturnal hemodialysis is ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... the "US Self-monitoring Blood Glucose Market" report ... This market insight focuses on the ... the United States . Reimbursement analysis and ... product analyses for more than 73 SMBG meters have ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3US Self-monitoring Blood Glucose Market 2Investment Analysis of the US Medical Device Sector 2
... Sept. 26, 2011 OncoSec Medical Incorporated (OTCBB: ... therapies to treat solid tumor cancers, announced today ... and Beyond: The Future of Ablation Therapies conference ... highlighted a poster titled, "OMS ElectroChemotherapy: Targeted Ablation ...
... 2011 Reportlinker.com announces that a new ... catalogue: Pharmaceutical Contract Manufacturing: ... http://www.reportlinker.com/p0629356/Pharmaceutical-Contract-Manufacturing-World-Market-Outlook-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical Report ... pharma contract manufacturing market perform from 2011? ...
Cached Medicine Technology:OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials 2OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials 3OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials 4Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 2Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 3Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 4Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 5Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 6Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 7Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 8Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 9Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 10Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 11
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: